Company intelligence
ProBio
Manufacturing Life-Changing Therapies
About ProBio
ProBio is a global contract development and manufacturing (CDMO) organization, which aims to accelerate the manufacturing of life-changing drugs, discover novel therapeutic targets, and develop innovative therapeutic approaches to manufacture best-in-class DNA, RNA, and protein-based therapeutics. As a global partner, ProBio brings together multi-disciplinary expertise to accelerate the manufacturing of advanced therapies, including biologics, protein and mRNA vaccines, viral vectors, antibody-drug conjugates and drug discovery services. We aid you in realizing the potential of your breakthrough discovery to treat diseases and improve lives. Let us accelerate your path to market with the greatest chance of success!
Verified activity
Signals from ProBio
4 published signals
Presence & Recognition
ProBio published an article in Drug Discovery News exploring how in vivo CAR-T is reshaping the future of cell therapy manufacturing.
Reported by ProBio
Presence & Recognition
ProBio and GenScript recognized Murali Jujjavarapu as Employee of Excellence for Genscript Day 2026.
Reported by Murali Jujjavarapu
Operations & Supply
ProBio announced that the Hopewell facility in New Jersey is being used to explore plasmid DNA and viral vector development and manufacturing capabilities.
Reported by ProBio
Presence & Recognition
ProBio is attending the BioProcess International 2026 conference in Boston from September 22 to 25, featuring Booth 931 to discuss development and manufacturing strategies for advanced biologics and cell and gene therapies.
Reported by ProBio